Condition: Opioid Use Disorder · Sponsor: Yale University
This study is a multisite double-blind, double-dummy, randomized clinical trial enrolling ED patients with untreated moderate to severe opioid use disorder (OUD) to compare Standard Dose Induction (SDI) and High Dose Induction (HDI) on rates of participation in OUD treatment within 10 days post randomization, and opioid withdrawal symptoms, opioid craving, and use of illicit and non-prescribed drugs.
This description comes directly from the study's public registry record.
Gail D'Onofrio, MD, MS · 2037857059 · gail.donofrio@yale.edu
Kathryn Hawk, MD, MHS · 2037857899 · kathryn.hawk@yale.edu
Always discuss trial participation with your own doctor first.
| Highland Hospital | Oakland, California, United States | Recruiting |
| San Leandro Hospital | San Leandro, California, United States | Recruiting |
| Maine Medical Center | Portland, Maine, United States | Recruiting |
| Cooper University Hospital | Camden, New Jersey, United States | Recruiting |
| University of Utah Hospital | Salt Lake City, Utah, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06494904